Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$57.18 -1.26 (-2.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biomarin Pharmaceutical (BMRN) Shares Outstanding (Diluted) (2009 - 2026)

Updated

Biomarin Pharmaceutical's Shares Outstanding (Diluted) came in at 194.47 million for Q2 2026, down 1.3% from 197.09 million a year earlier and down 1.6% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends

For FY2025, Biomarin Pharmaceutical's Shares Outstanding (Diluted) was 197.39 million, up 0.3% from FY2024.

  • Shares Outstanding (Diluted) has increased in each of the last four years, with a five-year compound annual growth rate of 0.6% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Diluted) was 196.71 million in FY2024 (+2.7%), 191.6 million in FY2023 (+1.4%), 188.96 million in FY2022 (+3.3%) and 182.85 million in FY2021 (-4.6%).
  • The five-year range for quarterly Shares Outstanding (Diluted) is 182.85 million (Q4 2021) to 200.51 million (Q2 2024).
  • Year-over-year, Shares Outstanding (Diluted) increased in four of the last eight quarters, with an average year-over-year change of 0.0%.
  • The fastest year-over-year change in Shares Outstanding (Diluted) over five years came in Q1 2022 (growth of 5.7%), and the weakest in Q3 2021 (a decline of 7.3%).
  • Business Quant data shows BMRN's Shares Outstanding (Diluted) at 197.67 million (Q1 2026), 197.39 million (Q4 2025) and 192.03 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Biomarin Pharmaceutical 11.61 Bn 5.48 Bn 786.91 Mn 194.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 194.47 Mn
Mar 31, 2026 197.67 Mn
Dec 31, 2025 197.39 Mn
Sep 30, 2025 192.03 Mn
Jun 30, 2025 197.09 Mn
Mar 31, 2025 196.47 Mn
Dec 31, 2024 196.71 Mn
Sep 30, 2024 197.15 Mn
Jun 30, 2024 200.51 Mn
Mar 31, 2024 199.26 Mn
Dec 31, 2023 191.60 Mn
Sep 30, 2023 191.17 Mn
Jun 30, 2023 195.00 Mn
Mar 31, 2023 194.36 Mn
Dec 31, 2022 188.96 Mn
Sep 30, 2022 185.60 Mn
Jun 30, 2022 187.45 Mn
Mar 31, 2022 194.89 Mn
Dec 31, 2021 182.85 Mn
Sep 30, 2021 183.21 Mn
API Access

Biomarin Pharmaceutical Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BMRN&period=max&api_key=YOUR_API_KEY